Symphony Environmental makes progress in battle against COVID-19

0
34
  • Symphony Environmental wins expanded FDA approval for antimicrobial food packaging
  • Symphony Environmental Technologies ‘milestone’ with FDA approval for antimicrobial food packaging
Symphony

Quick facts: Symphony Environmental Technologies PLC

Follow

View company profile

Symphony Environmental Technologies plc specializes in developing and marketing a wide range of plastic products and other environmental technologies, and operates worldwide.

14 Jul 2021

() said it received approval from the US Food & Drug Administration (FDA) for its d2p antimicrobial food contact technology alongside much greater loading of the technology and the wider use of its original bread-packaging approval announced in February last year.

The AIM-listed firm said that the FDA’s approval applies to all types of polyolefin and polyester film for wrapping bread, instead of just linear low-density polythene (LLDPE),. As a result, it expects an “acceleration of the commercial process in the near term”.

Symphony also said that pre-commercial trials for the US and other countries were already progressing in anticipation of the approval, with data showing “significant benefits” from the further enhanced, and now FDA-approved, d2p treated plastic films.

“This innovative multi-layer film treatment with d2p has been developed through our customer-focused trials following last year’s FDA approval. The benefits for our customers were already significant and so we are delighted to have obtained this more enhanced approval for our d2p bread applications in the USA. Symphony already generates significant revenues from the baking industry from our d2w biodegradable technology in plastic packaging, and we are seeing considerable interest in our FDA-approved, d2p antimicrobial technology for bread packaging. d2p is synergistic with d2w biodegradable technology and is expected to be sold to many of our current customers as well as new ones separately, or as a combined treatment”, Symphony chief executive Michael Laurier said in a statement.

Read more

13 Jul 2021

() gave a half-time report in which the board expressed confidence that full-year results would be in line with market expectations.

The AIM-listed group, which specialises in making plastics smarter, safer and more sustainable, said group revenue in the first half of 2021 rose to GBP4.9mln from GBP4.8mln in the same period of last year, and would have shown a 13% year-on-year increase to GBP5.4mln had exchange rates stayed unchanged from the first half of 2020.

Read more

13 May 2021

() said has received defence documents from the Commission, Parliament, and Council of the European Union.

All are defendants in a case being brought by Symphony, whose legal team will now take several weeks to assess what it has received.

Read more

16 Jul 2021

() Michael Laurier talks to Proactive London after receiving approval from the US Food & Drug Administration (FDA) for its d2p antimicrobial food contact technology.

Laurier explains the significance of this and the wider use of its original bread-packaging approval announced in February last year which now gives them ‘wide scope’ as a company.

As a result, Laurier is expecting ‘acceleration of the commercial process in the near term’ as he highlights the move as an ‘important milestone’.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash…

FOR OUR FULL DISCLAIMER CLICK HERE

Symphony Environmental Technologies ‘milestone’ with FDA approval for…

Symphony Environmental Technologies PLC (LON:SYM) Michael Laurier talks to Proactive London after receiving approval from the US Food & Drug Administration (FDA) for its d2p antimicrobial food contact technology.

Laurier explains the significance of this and the wider use of its…

15 hours, 42 minutes ago

3 min read

LEAVE A REPLY

Please enter your comment!
Please enter your name here